STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $4,834,000 | -54.5% | 998,677 | 0.0% | 0.07% | -47.2% |
Q4 2019 | $10,616,000 | +2.1% | 998,677 | 0.0% | 0.13% | -3.8% |
Q3 2019 | $10,396,000 | -20.9% | 998,677 | +16.4% | 0.13% | -19.0% |
Q2 2019 | $13,146,000 | +185.7% | 858,082 | +139.6% | 0.16% | +181.0% |
Q1 2019 | $4,601,000 | +265.7% | 358,082 | +170.4% | 0.06% | +222.2% |
Q4 2018 | $1,258,000 | -57.8% | 132,428 | -26.2% | 0.02% | -52.6% |
Q3 2018 | $2,978,000 | -13.2% | 179,409 | -16.0% | 0.04% | -20.8% |
Q2 2018 | $3,430,000 | +31.9% | 213,706 | +25.7% | 0.05% | +20.0% |
Q1 2018 | $2,601,000 | -14.7% | 169,995 | -13.0% | 0.04% | -9.1% |
Q4 2017 | $3,049,000 | +71.7% | 195,437 | +22.1% | 0.04% | +76.0% |
Q3 2017 | $1,776,000 | +387.9% | 160,000 | +649.4% | 0.02% | +400.0% |
Q4 2014 | $364,000 | +37.4% | 21,350 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $265,000 | – | 21,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |